日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination

接种KP.2单价mRNA疫苗后,针对SARS-CoV-2变异株LP.8.1、LF.7.1、NB.1.8.1、XFG和BA.3.2的抗体反应

Abbad, Anass; Lerman, Brian; Ehrenhaus, Jordan; Monahan, Brian; Singh, Gagandeep; Wilson, Adria; Slamanig, Stefan; Aracena, Ashley; Lyttle, Neko; Nardulli, Jessica R; Farrugia, Keith; Khalil, Zain; Gonzalez-Reiche, Ana Silvia; Sordillo, Mia Emilia; Sun, Weina; van Bakel, Harm; Simon, Viviana; Krammer, Florian

Correction: Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1

更正:在感染 HIV-1 的人群中,接种 COVID-19 mRNA 疫苗后 Fc 介导的抗体反应降低

Klingler, Jéromine; Rao, Priyanka Gadam; Bandres, Juan C; Pena, Ismael; Roldan, Katherine Bolanos; Singh, Gagandeep; Monahan, Brian; Gleason, Charles; Chen, Yuexing; Slamanig, Stefan; Sun, Weina; Upadhyay, Chitra; Hioe, Catarina E

Development of an RT-qPCR and a Next-Generation Sequencing approach to assess viral shedding of NDV-based SARS-CoV-2 variant vaccines

开发RT-qPCR和下一代测序方法来评估基于NDV的SARS-CoV-2变异疫苗的病毒脱落情况

Boza, Marta; Abdeljawad, Adam; Slamanig, Stefan; Lemus, Nicholas; Lai, Tsoi Ying; Shea, William; Sun, Weina; Palese, Peter; González-Domínguez, Irene

AddaVax, AddaS03, and Alum Effectively Enhance Cross-Reactive and Cross-Neutralizing Antibody Responses Against SARS-CoV-2 Induced by the Inactivated NDV-HXP-S Vaccine in Mice

AddaVax、AddaS03 和明矾可有效增强灭活 NDV-HXP-S 疫苗在小鼠体内诱导的针对 SARS-CoV-2 的交叉反应性和交叉中和性抗体反应。

Martínez-Guevara, José Luis; Lai, Tsoi Ying; Mishra, Mitali; Slamanig, Stefan; González-Domínguez, Irene; Abdeljawad, Adam; Hoang, Minh Thu; Singh, Gagandeep; Kowdle, Shreyas; Lee, Benhur; Krammer, Florian; Palese, Peter; Sun, Weina

Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters.

同源和异源 NDV 和 MVA SARS-CoV-2 疫苗在小鼠和仓鼠中的免疫原性和有效性。

Pérez Patricia, Jiang Kaijun, González-Domínguez Irene, Rodríguez-Martín Daniel, Abdeljawad Adam, Cupic Anastasija, Slamanig Stefan, Flores Sara, Noriega María A, Sánchez-Cordón Pedro J, Lemus Nicholas, Lai Tsoi Ying, Sun Weina, Esteban Mariano, García-Sastre Adolfo, García-Arriaza Juan

A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.

用于选择高滴度人类康复血浆以治疗感染严重急性呼吸综合征冠状病毒 2 变异株的免疫功能低下患者的替代酶联免疫吸附试验

Dolange Victoria, Slamanig Stefan, Abdeljawad Adam, Lai Tsoi Ying, Lemus Nicholas, Singh Gagandeep, Carreño Juan Manuel, Abbad Anass, Srivastava Komal, Simon Viviana, Sachithanandham Jaiprasath, Pekosz Andrew, Sullivan David, Krammer Florian, Sun Weina, Palese Peter, González-Domínguez Irene

Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1.

HIV-1感染者接种COVID-19 mRNA疫苗后,Fc介导的抗体反应降低。

Klingler Jéromine, Rao Priyanka Gadam, Bandres Juan C, Pena Ismael, Roldan Katherine Bolanos, Singh Gagandeep, Monahan Brian, Gleason Charles, Chen Yuexing, Slamanig Stefan, Sun Weina, Upadhyay Chitra, Hioe Catarina E

Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG and BA.3.2 following KP.2 monovalent mRNA vaccination.

KP.2 单价 mRNA 疫苗接种后对 SARS-CoV-2 变种 LP.8.1、LF.7.1、NB.1.8.1、XFG 和 BA.3.2 的抗体反应

Abbad Anass, Lerman Brian, Ehrenhaus Jordan, Monahan Brian, Singh Gagandeep, Wilson Adria, Slamanig Stefan, Aracena Ashley, Lyttle Neko, Nardulli Jessica, Farrugia Keith, Khalil Zain, Gonzalez-Reiche Ana Silvia, Sordillo Mia Emilia, Sun Weina, van Bakel Harm, Simon Viviana, Krammer Florian

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice.

三价 NDV-HXP-S 疫苗可保护小鼠免受系统发育上较远的 SARS-CoV-2 变异株的感染

González-Domínguez Irene, Martínez Jose Luis, Slamanig Stefan, Lemus Nicholas, Liu Yonghong, Lai Tsoi Ying, Carreño Juan Manuel, Singh Gagandeep, Singh Gagandeep, Schotsaert Michael, Mena Ignacio, McCroskery Stephen, Coughlan Lynda, Krammer Florian, García-Sastre Adolfo, Palese Peter, Sun Weina

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam

一项在越南开展的随机、安慰剂对照1/2期临床试验中,基于鸡蛋培养的表达SARS-CoV-2刺突蛋白的灭活新城疫病毒疫苗的安全性和免疫原性:中期结果

Duc Dang, Anh; Dinh Vu, Thiem; Hai Vu, Ha; Thanh Ta, Van; Thi Van Pham, Anh; Thi Ngoc Dang, Mai; Van Le, Be; Huu Duong, Thai; Van Nguyen, Duoc; Lawpoolsri, Saranath; Chinwangso, Pailinrut; McLellan, Jason S; Hsieh, Ching-Lin; Garcia-Sastre, Adolfo; Palese, Peter; Sun, Weina; Martinez, Jose L; Gonzalez-Dominguez, Irene; Slamanig, Stefan; Manuel Carreño, Juan; Tcheou, Johnstone; Krammer, Florian; Raskin, Ariel; Minh Vu, Huong; Cong Tran, Thang; Mai Nguyen, Huong; Mercer, Laina D; Raghunandan, Rama; Lal, Manjari; White, Jessica A; Hjorth, Richard; Innis, Bruce L; Scharf, Rami